SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-011798
Filing Date
2018-05-08
Accepted
2018-05-08 16:05:59
Documents
2
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AERI-8-K-05.08.18 PRESS RELEASE aeri-8k_20180508.htm 8-K 36990
2 EX-99.1 aeri-ex991_6.htm EX-99.1 281262
  Complete submission text file 0001564590-18-011798.txt   319435
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 18814538
SIC: 2836 Biological Products, (No Diagnostic Substances)